Spenco Insoles and 2nd Skin Medical Adhesive Assets

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Spenco Insoles and 2nd Skin Medical Adhesive Assets - overview

Established

1967

Location

Waco, TX-Texas, US

Primary Industry

Healthcare

About

Spenco specializes in science-based foot health products, enhancing comfort and reducing pain for both casual and professional users through premium insoles and skin care solutions designed for active lifestyles. Spenco is known for its innovative foot health solutions. Founded in the US, the company has maintained operations in Waco, Texas. In June 2016, it was acquired by Implus Footcare, LLC, a company within the Berkshire Partners portfolio.


This acquisition marked a key transition in Spenco's operational strategy. Spenco US specializes in science-based foot health products designed to enhance comfort, reduce pain, and improve athletic performance. The company’s core offerings include premium insoles that provide support, cushioning, and energy return, suitable for individuals engaged in various physical activities. Spenco addresses common foot-related issues such as plantar fasciitis and lower limb fatigue, with a product line that has expanded since its inception in 1967 to include skin care products aimed at soothing and protecting skin.


Their products are distributed across North America and have a growing presence in international markets. Spenco US generates revenue through direct-to-consumer sales along with partnerships with retailers and wholesalers. Their sales model emphasizes B2C transactions via their online platform, where consumers can purchase flagship products such as their renowned insoles directly. They engage in distribution agreements with various retailers, which expands their market reach.


Their sales structure typically involves one-time purchases of premium foot care products and repeat business from loyal customers who rely on Spenco’s solutions for their ongoing foot health needs. The company plans to leverage its recent acquisition by Implus Footcare, LLC, to enhance its product offerings and expand into new markets. Upcoming products are currently being designed, although specific details regarding release dates are not disclosed. The company is focused on expanding its geographical reach, particularly targeting international markets to increase accessibility to its foot care solutions.


The acquisition in June 2016 provides the necessary capital and strategic direction to support these growth initiatives.


Current Investors

Implus Footcare LLC

Primary Industry

Healthcare

Sub Industries

Consumer Products, Aesthetic Medicine, Alternative Medicine, Biomaterials

Website

www.spenco.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Spenco Insoles and 2nd Skin Medical Adhesive Assets - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSpenco Insoles and 2nd Skin Medical Adhesive Assets-

Displaying 1 - 1 of 1

Spenco Insoles and 2nd Skin Medical Adhesive Assets - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.